FierceBiotech 17 dic 2025 Medtronic rolls out new peripheral thrombectomy system while making advances in brain bleeds
FierceBiotech 17 dic 2025 Nektar claims phase 2 alopecia success after excluding patients who ‘should never have been enrolled’
FierceBiotech 16 dic 2025 December deal flurry rolls on with Genentech-Caris cancer collab worth up to $1.1B
FierceBiotech 16 dic 2025 Xoma acquires another struggling biotech, this time zeroing in on Generation Bio
FierceBiotech 16 dic 2025 Aldeyra dry eye disease candidate hit by FDA delay amid shifting agency guidance, biotech says
FierceBiotech 16 dic 2025 Ramaswamy-backed Ambros Therapeutics launches with $125M to develop pain drug
FierceBiotech 16 dic 2025 Sanofi signs $1B biobucks pact for Alzheimer’s asset in 2nd biotech deal of the day
FierceBiotech 15 dic 2025 J&J-backed Link launches with $60M, plan to create next-gen CAR-T therapies
FierceBiotech 15 dic 2025 Kyverna gains clear view to first CAR-T approval for autoimmune disease after 'truly remarkable' SPS readout